Regent Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL - safety alert

Official notice

27 Jul 2026

Last checked

27 Jul 2026

Medium riskFDA

An official FDA notice concerns Regent Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL - safety alert. An official FDA notice concerns Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL. The notice reports a health risk requiring medical assessment. Do not use the product and dispose of it as directed. Published 2026-07-27. Lots: 25202. Check the official notice for the complete list. Published 2026-07-27.

What to do now

The source does not provide specific consumer instructions. Follow the official FDA notice for next steps.

Official notice

2026-07-27

The hazard

An official FDA notice concerns Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL. The notice reports a health risk requiring medical assessment. Do not use the product and dispose of it as directed. Published 2026-07-27. Lots: 25202. Check the official notice for the complete list.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Lots

25202

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL

Risk / hazard

An official FDA notice concerns Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL. The notice reports a health risk requiring medical assessment. Do not use the product and dispose of it as directed. Published 2026-07-27. Lots: 25202. Check the official notice for the complete list.

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

US · United States

Affected area 1

US · United States

Company & contacts

Brand

Manufacturer

Not provided

Phone

(800) 645-1706

Brand: Regent. Contact: American Regent, Inc.. Phone (800) 645-1706.

Source & status

Source

Tier

official

Category

HEALTH

App estimate

medium

Recall details

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

US
Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial - safety alertImage: FDA recall notice

Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) multi dose vial - safety alert

Risk not stated by sourceFDA3 Sept 2026
US
No image published for this recall

a product listed in the official notice - safety alert

Medium riskFDA7 May 2025
US
No image published for this recall

a product listed in the official notice - safety alert

Medium riskFDA11 Dec 2024
US
Cefazolin in Dextrose Injection - safety alertImage: FDA recall notice

Cefazolin in Dextrose Injection - safety alert

Risk not stated by sourceFDA24 Jul 2026
US
a product listed in the official notice - safety alertImage: FDA recall notice

a product listed in the official notice - safety alert

mediumFDA28 Apr 2026

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 27 Jul 2026. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.